The Patent Finder
US

Nutritional Supplement for Improving Sexual Health in Men and Women

US 10,864,205 Lapsed on the fee record
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Feb 10, 2022 (Avenue Venture Opportunities Fund II, L.P.).

Lapsed Dec 15, 2024 on the fee record · High confidence

First maintenance fee unpaid; grace period ended.

Filed Dec 1, 2017 as application 15/829,822 · Granted Dec 15, 2020
Base term, 20 years from filing
Today
Lapsed Dec 15, 2024
2017 2037
Clock starts
Dec 1, 2017
No longer in force
Dec 15, 2024
Granted
Dec 15, 2020
Term would have run to
Dec 1, 2037
base term after the term ends Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,500,199, to Dec 1, 2037. The term already ends on or before that date, so the cap shortened nothing.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
28
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

Its term would have run to Dec 1, 2037: its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Dec 1, 2017, when this application, 15/829,822, was filedDec 1, 2037High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,500,199)resolves to Dec 1, 2037, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidlapsed Dec 15, 2024High confidence
Computed term endThe steps above, in orderDec 15, 2024High confidence

This family

US 10,399,189In force
Jul 2038
Jul 2038
Application 62/505,514Pending
not computed
not computed
Application 62/590,756Pending
not computed
not computed
Application 15/829,797Abandoned
not computed
not computed
US 10,758,505Lapsed on the fee record
Sep 2024
Sep 2024
Application 15/829,799Abandoned
not computed
not computed
US 10,500,199Lapsed on the fee record
Dec 2023
Dec 2023
US 10,864,205this patent
Dec 2024
Dec 2024
8 of 28 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Nov 29, 2018
Reel 47624, frame 203
Damaj, BassamInnovus Pharmaceuticals, Inc.Assignment of Assignor's Interest
Jan 27, 2022
Reel 58789, frame 1
Innovus Pharmaceuticals, Inc.; Semprae Laboratories, Inc.Eclipse Business Capital LLC (F/K/A Encina Business Credit, LLC), as AgentSecurity Interest
Feb 10, 2022
Reel 58976, frame 706
Innovus Pharmaceuticals, Inc.Avenue Venture Opportunities Fund II, L.P.Security Interest
Oct 16, 2023
Reel 65241, frame 560
Eclipse Business Capital LLC (F/K/A Encina Business Credit, LLC), as AgentInnovus Pharmaceuticals, Inc.; Semprae Laboratories, Inc.; Aytu Biopharma, Inc.; Novalere, Inc.Partial Release of Security Interest in Patents
Oct 16, 2023
reel/frame not recorded
Eclipse Business Capital LLC (F/K/A Encina Business Credit, LLC), as AgentInnovus Pharmaceuticals, Inc.Partial Release of Security Interest in Patents
Oct 16, 2023
reel/frame not recorded
Eclipse Business Capital LLC (F/K/A Encina Business Credit, LLC), as AgentSemprae Laboratories, Inc.Partial Release of Security Interest in Patents
Oct 16, 2023
reel/frame not recorded
Eclipse Business Capital LLC (F/K/A Encina Business Credit, LLC), as AgentAytu Biopharma, Inc.Partial Release of Security Interest in Patents
Oct 16, 2023
reel/frame not recorded
Eclipse Business Capital LLC (F/K/A Encina Business Credit, LLC), as AgentNovalere, Inc.Partial Release of Security Interest in Patents
Jun 14, 2024
Reel 67728, frame 206
Avenue Venture Opportunities Fund, L.P.Innovus Pharmaceuticals, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited